IT’S A STORY
The Centers for Disease Control says that despite high blood pressure risks, vaccination should be stopped.
U.S. medical team says Friday is the time to re-use Johnson & Johnson’s COVID-19 vaccine, even if you’re at high risk blood clots.
A directive from the Centers for Disease Control and Prevention (CDC) paves the way for the J&J shooting to resume in the United States after regulators suspended its use last week to review reports of rare but dangerous blood transfusions combined with low blood pressure.
CDC experts say on Friday the benefits of the vaccine outweigh the serious but small risks – especially against the virus that still infects tens of thousands of Americans daily. The government should consider such factors as the following:
Health officials say they expect to be re-introduced as soon as possible.
“These benefits outweigh the risks to individuals and their attitudes,” said Dr Bell Bell, a member of the consulting team and professor of medicine at the Department of Global Health at the University of Washington in Seattle.
“It’s a new accident. It will definitely be a much smaller and smaller risk compared to the many other risks we face each day, ”he added.
Of the nearly eight million people who received the vaccine before the U.S. stopped the J&J shooting earlier this month, health officials have uncovered 15 cases of blood transfusion, three of which are fatal. All were women, less than 50.
The CDC and the Food and Drug Administration (FDA) initially saw six people who started freezing three weeks after receiving the J&J vaccine, including one death. The investigation then escalated as the government received what Walensky called “few” extra clot reports including the death that government officials say is being investigated in Oregon.
The needle-haystack reports were alarming because European regulators had already revealed unequal scars among the recipients of another COVID-19 vaccine, from Oxford-AstraZeneca. AstraZeneca and J&J shots, though not identical, are made with the same technology.
European scientists have found evidence that the specific dosage of AstraZeneca vaccines can be blamed – and if so, doctors should avoid the most common, blood-thinning drug called heparin.
This increased the urgency of U.S. authorities to stop the J&J vaccine so that they could tell doctors how to diagnose and treat this rare disease. The first few patients are treated with heparin before each realizes it may be harmful rather than helpful to patients.